Management Team

Meet the Team

John Gobron

John Gobron

Chief Executive Officer

John Gobron brings 23 years of experience and expertise leading healthcare software and service organizations in the US and Europe. Prior to joining SafeDose, John was the CEO at Aventura Software, leading the growth and development of the industry’s first location-aware interoperability platform.

Prior to Aventura, John led Symantec’s $130M Americas Healthcare Vertical and also performed as the EMEA General Manager at Sentillion where he helped facilitate the company’s acquisition by Microsoft. He then stayed on to lead Microsoft’s Health Solutions business in the UK.

John also served as CEO of USTeleHealth, a leading telephone nurse triage company, and led the company from startup to a successful acquisition.

Michael Strange

Michael Strange

Chief Technology Officer

Senior technology executive with a passion for driving IT transformation and innovation through advanced technologies such as AI and Machine Learning. Managed hundreds of complex IT transformational initiatives for Fortune 500 as well as nonprofit organizations. Combines action-oriented leadership style, modern architectures and mentoring to create a positive working environment. Authored 21 patents for technology solutions.
Jacci Patterson, RN

Jacci Patterson, RN

Chief Operating Officer

After obtaining her nursing degree from the University of Michigan, Jacci spent several years working as a bedside nurse in pediatrics. Her experience includes Pediatric Hematology and Oncology, Pediatric Bone Marrow and Stem Cell Transplant, Pediatric Intensive Care, Pediatric Mobile Critical Care, and general pediatrics. She received training at several major university hospitals including Duke Medical Center, University of North Carolina Medical Center, and Oregon Health Sciences University, and gained experience working at a large city hospital with a Level I trauma center.

Jacci transitioned into the field of pharmacovigilance in 2006 when she began working in drug safety on clinical trials for experimental medications. Most of the clinical studies were adult oncology but also included neurologic, endocrine, and reproductive indications. She gained global experience while working with foreign physicians and hospitals that participated in the clinical trials.

In 2013 she joined the SafeDose team as the Vice President of Clinical Content and provides nursing review of the system.